GoldBamboo.com - Knowledge is strong medicine
  

Motivational and Skills for THC/ETOH+ Teens in Jail - Article


  Not Signed In - Sign In / Register






Drug Abuse

Hallucinogens; Methadone; Narcotics; PCP (Phencyclidine)


Clinical Trial: Motivational and Skills for THC/ETOH+ Teens in Jail

This study is not yet open for patient recruitment.
Verified by Brown University May 2005

Sponsors and Collaborators: Brown University
National Institute on Drug Abuse (NIDA)
Information provided by: Brown University
ClinicalTrials.gov Identifier: NCT00249028

Purpose

The pupose of this study is to test the efficacy of individual MI and group CBT for reducing alcohol and marijuana-related harm as well as alcohol and maurjuana use in incarcerated youth.
Condition Intervention Phase
Alcohol Abuse
Marijuana Abuse
 Behavior: Behavior therapy
Phase II

MedlinePlus related topics:  Alcoholism;   Marijuana

Study Type: Interventional
Study Design: Treatment, Randomized, Double-Blind, Active Control, Single Group Assignment, Efficacy Study

Further study details as provided by Brown University:
Primary Outcomes: Timeline followback; Urine drug screen
Expected Total Enrollment:  200

Study start: November 2005;  Expected completion: July 2010
Last follow-up: March 2009;  Data entry closure: April 2010

This study will focus on treating substance abusing incarcerated teens using 2 individually administered motivational interviewing sessions followed by 10 group sessions of cognitive behavior therapy (CBT). Motivational Interviewing (MI)is conceptualized as preparation for group CBT. The control group receives individualized relaxation training (RT)followed by group treatment as usual(TU). In this propozed randomized trial a one way design (MI/CBT v. RT/TU) will be used to determine whether MI/CBT enhances group therapy participation and reduces substance use and related problems (e.g., crime, injuries) post discharge in substance involved juvenile delinquents. RT/TU is based on the 12 step model and includes psychoeducational components. Participants are followed during incarceration and for 6 months post incarceration. Primary outcome variables include alcohol and marijuana use, as well as related behaviors (illegal activity, sex or injuries while drunk or high). It is hypothesized that in comparison to teens in RT/TU youth receiving MI/CBT will participate more in therapy (accroding to teen, facility staff, and counselor ratings) and will show lower levels of substance use and related problems after discharge. Frequently substance abuse treatment is unavailable to youths in the juvenile justice system and when treatment is available it may be provided in group format using untested therapies. A motivation/skills based intervention (delivered in group format) may prove efficacious in enhancing motivation and in reducing substance abuse and related problems. This study extends previous research by rigorously evaluating group treatment for incarcerated teens. We will examine processes contributing to the efficacy of group MI/CBT and the influence of race and ethnicity on treatment effects. The development of effective interventions for substance using juvenile offenders has the potential to reduce substance abuse and crime in this population.

Eligibility

Ages Eligible for Study:  14 Years   -   19 Years,  Genders Eligible for Study:  Both

Accepts Healthy Volunteers

Criteria

Inclusion Criteria:

- In the year prior to incarceration used mj regularly (monthly) In the year prior to incarceration drank regularly (monthly) or binged (>=5 boys; >=4 girls).

Used mj or drank in 4 weeks prior to offense for which they were incarcerated Used mj or drank in 4 weeks before incarcerated 14-19 years of age 4-12 month sentence length

Exclusion Criteria:

-

Location and Contact Information

Please refer to this study by ClinicalTrials.gov identifier  NCT00249028


Rhode Island
      Rhode Island Training School, Cranston,  Rhode Island,  02920,  United States
Charles Golembesky, PhD  401-462-7208    Chuck.Golembeski@DCYF.RI.GOV 
Charles Golumbesky, Ph.D,  Sub-Investigator

Study chairs or principal investigators

Lynda Stein, Ph.D.,  Principal Investigator,  Brown University   

More Information

Study ID Numbers:  DA18851
Last Updated:  December 8, 2005
Record first received:  November 4, 2005
ClinicalTrials.gov Identifier:  NCT00249028
Health Authority: United States: Institutional Review Board
ClinicalTrials.gov processed this record on 2006-01-10


Take control over your directory listings...INSTANTLY

Every day, thousands of users find businesses like yours in the GoldBamboo directory.

Limited Time Offer!!!

For only $50 a year, a savings of 50% off our standard rate:

  • Edit your listing (whenever you want!)
  • Link to your website
  • Choose which categories you are listed in
  • Describe your services

The process will take only a few minutes and consists of 3 easy steps:

1. Register     >     2. Edit Listings     >     3. Publish

Your Company
your street
yourtown, YS 12345
888-888-8888



No Thanks

Popular Treatments

Acne Treatment ADHD Treatment Allergy Treatment Alzheimer's Treatment
Anemia Treatment Arthritis Treatment Asthma Treatment Bipolar Disorder Treatment
Bird Flu Treatment Bladder Cancer Treatment Bladder Control Treatment Blood Pressure Treatment
Brain Tumor Treatment Breast Cancer Treatment Bronchitis Treatment Cancer Treatment
Cancer Alternative Treatment Cataract Treatment Cirrhosis Treatment Colitis Treatment
Colon Cancer Treatment Common Cold Treatment Conjunctivitis Treatment Constipation Treatment
Crohn's Disease Treatment Cystic Fibrosis Treatment Depression Treatment Dermatitis Treatment
Diabetes Treatment Edema Treatment Epilepsy Treatment Erectile Dysfunction Treatment
Fibromyalgia Treatment GERD Treatment Glaucoma Treatment Gout Treatment
Hay Fever Treatment Headache Treatment Heart Disease Treatment Hepatitis Treatment
High Blood Pressure Treatment High Cholesterol Treatment Hives Treatment Hypertension Treatment
Hypoglycemia Treatment IBS Treatment Impotence Treatment Indigestion Treatment
Infertility Treatment Influenza Treatment Insomnia Treatment Lactose Intolerance Treatment
Leukemia Treatment Lung Cancer Treatment Lyme Disease Treatment Macular Degeneration Treatment
Menopause Treatment Migraine Treatment Osteoarthritis Treatment Osteoporosis Treatment
Pancreatic Cancer Treatment PMS Treatment Pneumonia Treatment Prostate Diseases Treatment
Restless Leg Treatment Rheumatoid Arthritis Treatment Sepsis Treatment Sinusitis Treatment
Skin Cancer Treatment Sleep Apnea Treatment Snoring Treatment Stroke Treatment
Testicular Cancer Treatment
GoldBambooTM

Your Integrative Health and Wellness Resource for Drug Abuse.

October 6, 2008



Page Updated: October 3, 2005
Disclaimer: All material displayed on the GoldBamboo.com website is provided for educational purposes only. Consult a physician regarding the applicability of any information found on GoldBamboo.com to your symptoms or medical condition.

Massachusetts Law | Home | About Us | Link To Us | Feedback | Disclaimer | Privacy Policy | Terms of Use | Google Co-op | Health Forums

Copyright © 2004-2008 - Gold Bamboo LLC
All rights reserved.

HONcode accreditation seal.

We comply with the HONcode standard for health trust worthy information:
verify here.